Evidence map›Paper›PMID 41146350›Full record

ArticleMilitary Medical Research2025

Trace element-dictated exosome modules and self-adaptive dual-network hydrogel orchestrate diabetic foot regeneration through complement-mitochondria-autophagy circuitry.

Shuang-Qing Wang, Ming-Ji Jin, Ze-Ke Guo, Dong-Ri Shen, Li-Na Jin, Fang Cheng, Yan-Ru Zhao, Teng Liu, Yu-Cai Li, Nuo-Ya Wang and 4 more

Abstract read
In one paragraph

Article in Military Medical Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Nutrients · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shuang-Qing WangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.ORCID 0000-0003-0270-1305
Ming-Ji JinState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Ze-Ke GuoLangfang Kangbao Huitai Biotechnology Co. Ltd, Langfang, 065001, Hebei, China.
Dong-Ri ShenLan-Jayeon Medical Device Co., Ltd, Beijing, 100050, China.
Li-Na JinLan-Jayeon Medical Device Co., Ltd, Beijing, 100050, China.
Fang ChengLangfang Kangbao Huitai Biotechnology Co. Ltd, Langfang, 065001, Hebei, China.
Yan-Ru ZhaoLangfang Kangbao Huitai Biotechnology Co. Ltd, Langfang, 065001, Hebei, China.
Teng LiuLangfang Kangbao Huitai Biotechnology Co. Ltd, Langfang, 065001, Hebei, China.
Yu-Cai LiLangfang Kangbao Huitai Biotechnology Co. Ltd, Langfang, 065001, Hebei, China.
Nuo-Ya WangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Ling-Qing ChenState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Wei HuangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Xiu-Quan QuanEmergency Department, Yanbian University Hospital, Yanji, Jilin, 133000, China.
Zhong-Gao GaoState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. zggao@imm.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic foot ulcers (DFU), perpetually trapped in a vicious cycle of inflammation and ischemia, remain a significant clinical challenge. Exosomes (Exo) therapy holds promise for tissue repair, yet its functional potency and delivery efficiency are often limited.

methodsWe proposed an integrated strategy combining trace elements (TE) programming, Exo engineering, and intelligent delivery to overcome both functional and delivery constraints. Multiple TE (Fe, Mg, Zn, Mn, and Se) were incorporated into a three-dimensional (3D) dynamic culture system to construct high-activity engineered Exo (3D-TE-Exo). The biological mechanisms were explored via transcriptomics, mitochondrial function assays, and oxidative stress analyses. A dual-network hydrogel, incorporating dynamic Schiff base bonds and ultraviolet (UV)-triggered disulfide bond reorganization, was developed for precise and sustained Exo release in vivo.

results3D-TE-Exo achieved a yield of 1.9 × 10

conclusionsThis study presents a synergistic approach integrating engineered Exo and smart biomaterials to accelerate DFU healing. The platform offers a multi-target intervention strategy with strong translational potential for the clinical management of chronic wounds.

Indexed as

Diabetic FootExosomesHydrogelsRegenerationTrace ElementsAnimalsAutophagyMaleMitochondriaRatsRats, Sprague-DawleyWound HealingHydrogelsTrace ElementsComplement 1q binding protein (C1QBP)Diabetic foot ulcers (DFU)Exosomes (Exo)HydrogelTrace element

Identifiers

PMID41146350
PMCPMC12560296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.